Company Filing History:
Years Active: 2023
Title: Felicia Cao: Innovator in Cancer Gene Therapy
Introduction
Felicia Cao is a prominent inventor based in Houston, TX (US), known for her groundbreaking work in cancer gene therapy. She has made significant contributions to the field, particularly in developing methods that enhance the body's ability to combat cancer.
Latest Patents
Felicia Cao holds 1 patent for her innovative approach to cancer treatment. Her patent focuses on cancer gene therapy targeting CD47. The invention involves methods and compositions that block CD47, allowing tumor-associated macrophages (TAMs) to phagocytose and eliminate tumor cells. The therapy includes fusions of entities that bind CD47 and those that bind cells with FC receptors, enhancing the efficacy of the treatment. Specific embodiments of her work utilize gene therapy to produce a fusion of the ectodomain of SIRPa and the constant region of IgG4 at localized tumor sites, thereby increasing the therapeutic impact while minimizing potential toxicities.
Career Highlights
Felicia Cao is affiliated with Baylor College of Medicine, where she continues her research and development in cancer therapies. Her work has garnered attention for its innovative approach to treating cancer, particularly through the manipulation of immune responses.
Collaborations
Felicia collaborates with Stephen M G Gottschalk, a fellow researcher in the field. Their partnership enhances the potential for breakthroughs in cancer treatment through shared expertise and resources.
Conclusion
Felicia Cao's contributions to cancer gene therapy represent a significant advancement in the fight against cancer. Her innovative methods and dedication to research continue to inspire progress in medical science.